LGND  valuation analysis

Basics
Name: Ligand Pharmaceuticals Incorporated
Description: Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. (more)
Industry: Biotechnology
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: May 03, 2021
Market cap: $1.93B (1067th)
Sales(TTM): $208.41M (1353rd)
Earnings(TTM): $39.25M (998th)

Value
FFER: 3.04 (why)
Actual price: $115.82
FFEThis is Ligand Pharmaceuticals Incorporated's the estimated price. FFEs are the denominator of the FFER ratio.: $38.12
Quantile: LGND is very expensive given its fundamentals.
Prices as of EOD 2021-07-15
Price & Estimates
Sales & Earnings history (TTM)
Notable
  • Ligand Pharmaceuticals Incorporated's earnings increased from -$61.17M to $39.25M in the last year.
  • Ligand Pharmaceuticals Incorporated's operating income increased from -$15.68M to $9.66M in the last year.
Earnings / MarketCap
Ligand Pharmaceuticals Incorporated
"Biotechnology" industry
Sales / MarketCap
Ligand Pharmaceuticals Incorporated
"Biotechnology" industry
Book / MarketCap
Ligand Pharmaceuticals Incorporated
"Biotechnology" industry
Equity / Assets
Ligand Pharmaceuticals Incorporated
"Biotechnology" industry